Equity Analysis

Quarterly Results

    Krebs Biochemicals & Industries Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    524518
    INE268B01013
    -60.3642285
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    KREBSBIO
    0
    183.26
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales11.4712.8612.89
Other Operating Income0.000.000.00
Other Income 0.250.090.03
Total Income11.7212.9412.92
Total Expenditure 16.1815.5715.09
PBIDT-4.46-2.62-2.16
Interest 1.561.421.32
PBDT-6.02-4.05-3.48
Depreciation1.721.711.69
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-7.74-5.76-5.17
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-7.74-5.76-5.17
EPS (Unit Curr.)-3.59-2.67-2.40
EPS (Adj) (Unit Curr.)-3.59-2.67-2.40
Calculated EPS (Unit Curr.)-3.59-2.67-2.40
Calculated EPS (Adj) (Unit Curr.)-3.59-2.67-2.40
Calculated EPS (Ann.) (Unit Curr.)-14.36-10.69-9.59
Calculated EPS (Adj) (Ann.) (Unit Curr.)-14.36-10.69-9.59
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity21.5621.5621.56
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-38.88-20.37-16.76
PBDTM(%)-52.48-31.49-27.00
PATM(%)-67.48-44.79-40.11
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-3.59-2.67-2.40